ArticleThe Lancet. Oncology2024
Carcinogenicity of talc and acrylonitrile.
Abstract readNews
In one paragraph
Article in The Lancet. Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Review
- Associations of volatile organic compounds with cancer: A cross-sectional analysis of single and mixture exposures.The Journal of international medical research · 2026Article
- European Code Against Cancer, 5th edition - occupational exposures and cancer.Molecular oncology · 2026Review
- FIGO committee opinion: Environmental drivers of gynecologic and reproductive health.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Article
- Associations of volatile organic compounds with accelerated epigenetic aging in the lungs of smokers and electronic cigarette users.The Science of the total environment · 2025Article
- Talc, ovarian cancer, and recall bias in the sister study.Global epidemiology · 2025Article
- The key characteristics concept.Current opinion in toxicology · 2025Article
- Irregularities in the IARC Working Group Evaluation of Ramazzini Institute Aspartame Studies.Annals of global health · 2025Article
- Five decades of occupational cancer epidemiology.Scandinavian journal of work, environment & health · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Leslie T StaynerInternational Agency for Research on Cancer, Lyon, France.
Tania Carreón-ValenciaInternational Agency for Research on Cancer, Lyon, France.
Paul A DemersInternational Agency for Research on Cancer, Lyon, France.
Jason M FritzInternational Agency for Research on Cancer, Lyon, France.
Malcolm R SimInternational Agency for Research on Cancer, Lyon, France.
Patricia StewartInternational Agency for Research on Cancer, Lyon, France.
Hiroyuki TsudaInternational Agency for Research on Cancer, Lyon, France.
Andres CardenasInternational Agency for Research on Cancer, Lyon, France.
Dario ConsonniInternational Agency for Research on Cancer, Lyon, France.
Laurie DaviesInternational Agency for Research on Cancer, Lyon, France.
Sara De MatteisInternational Agency for Research on Cancer, Lyon, France.
Emanuela Felley-BoscoInternational Agency for Research on Cancer, Lyon, France.
Andrew J GhioInternational Agency for Research on Cancer, Lyon, France.
Thomas GöenInternational Agency for Research on Cancer, Lyon, France.
Yann GrosseInternational Agency for Research on Cancer, Lyon, France.
Alessandro F GualtieriInternational Agency for Research on Cancer, Lyon, France.
P David JosephyInternational Agency for Research on Cancer, Lyon, France.
Stella KoutrosInternational Agency for Research on Cancer, Lyon, France.
Igor LinhartInternational Agency for Research on Cancer, Lyon, France.
Henriqueta LouroInternational Agency for Research on Cancer, Lyon, France.
Katie M O'BrienInternational Agency for Research on Cancer, Lyon, France.
Simona PanzacchiInternational Agency for Research on Cancer, Lyon, France.
Laura PeñaInternational Agency for Research on Cancer, Lyon, France.
Pavel RössnerInternational Agency for Research on Cancer, Lyon, France.
Joellen M SchildkrautInternational Agency for Research on Cancer, Lyon, France.
Aleksandr B StefaniakInternational Agency for Research on Cancer, Lyon, France.
Nicolas WentzensenInternational Agency for Research on Cancer, Lyon, France.
Pascal WildInternational Agency for Research on Cancer, Lyon, France.
Yuanyuan XuInternational Agency for Research on Cancer, Lyon, France.
Aline de ContiInternational Agency for Research on Cancer, Lyon, France.
Caterina FacchinInternational Agency for Research on Cancer, Lyon, France.
Roland WedekindInternational Agency for Research on Cancer, Lyon, France.
Ayat AhmadiInternational Agency for Research on Cancer, Lyon, France.
Jessica BlancoInternational Agency for Research on Cancer, Lyon, France.
Shirisha ChittiboyinaInternational Agency for Research on Cancer, Lyon, France.
Shalini KulasingamInternational Agency for Research on Cancer, Lyon, France.
Richard MacLehoseInternational Agency for Research on Cancer, Lyon, France.
Melitah MotlhaleInternational Agency for Research on Cancer, Lyon, France.
Sanam ShahInternational Agency for Research on Cancer, Lyon, France.
Eero SuonioInternational Agency for Research on Cancer, Lyon, France.
Heidi MattockInternational Agency for Research on Cancer, Lyon, France.
Andrew KunzmannInternational Agency for Research on Cancer, Lyon, France.
Federica MadiaInternational Agency for Research on Cancer, Lyon, France.
Elisa PasqualInternational Agency for Research on Cancer, Lyon, France.
Lamia Benbrahim-TallaaInternational Agency for Research on Cancer, Lyon, France.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer, Lyon, France.
Funding
EVALUATION OF CARCINOGENIC RISKS TO HUMANSU01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 1985 to 2020
$16.5MIARC Monographs on the Identification of Carcinogenic Hazards to HumansR01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 2021 to 2025
$4.9MNCI NIH HHS R01 CA033193NCI NIH HHS U01 CA033193World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
AcrylonitrileTalcAnimalsCarcinogensHumansOccupational ExposureAcrylonitrileCarcinogensTalc
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.